Literature DB >> 8063407

Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins.

A A Beharka1, J W Armstrong, J J Iandolo, S K Chapes.   

Abstract

Macrophages from C2D transgenic mice deficient in the expression of major histocompatibility complex (MHC) class II proteins were used to identify binding sites for superantigens distinct from the MHC class II molecule. Iodinated staphylococcal enterotoxins A and B (SEA and SEB) and exfoliative toxins A and B (ETA and ETB) bound to C2D macrophages in a concentration-dependent and competitive manner. All four toxins increased F-actin concentration within 30 s of their addition to C2D macrophages, indicating that signal transduction occurred in response to toxin in the absence of class II MHC. Furthermore, ETA, ETB, SEA, and, to a lesser extent, SEB induced C2D macrophages to produce interleukin 6. Several molecular species on C2D macrophages with molecular masses of 140, 97, 61, 52, 43, and 37 kDa bound SEA in immunoprecipitation experiments. These data indicate the presence of novel, functionally active toxin binding sites on murine macrophages distinct from MHC class II molecules.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Substances:

Year:  1994        PMID: 8063407      PMCID: PMC303047          DOI: 10.1128/iai.62.9.3907-3915.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.

Authors:  D H Beezhold; G K Best; P F Bonventre; M Thompson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

3.  Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.

Authors:  T Ikejima; S Okusawa; J W van der Meer; C A Dinarello
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

4.  Functional discrimination between interleukin 6 and interleukin 1.

Authors:  M Helle; L Boeije; L A Aarden
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

5.  Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; Z A Gillis
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

6.  Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.

Authors:  B G Stiles; S Bavari; T Krakauer; R G Ulrich
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Specific receptor binding of staphylococcal enterotoxins by murine splenic lymphocytes.

Authors:  S Buxser; P F Bonventre; D L Archer
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

9.  Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.

Authors:  D J Fast; P M Schlievert; R D Nelson
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.

Authors:  T H Howard; W H Meyer
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  8 in total

Review 1.  The potential role of superantigens in inflammatory bowel disease.

Authors:  R A Kay
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

2.  Macrophage cell lines derived from major histocompatibility complex II-negative mice.

Authors:  A A Beharka; J W Armstrong; S K Chapes
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.416

3.  Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes.

Authors:  Roman Reddy Ganta; Melinda J Wilkerson; Chuanmin Cheng; Aaron M Rokey; Stephen K Chapes
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Staphylococcal enterotoxins bind H-2Db molecules on macrophages.

Authors:  A A Beharka; J J Iandolo; S K Chapes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

Review 6.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.

Authors:  J B Kline; C M Collins
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 8.  Superantigens and pseudosuperantigens of gram-positive cocci.

Authors:  B Fleischer; D Gerlach; A Fuhrmann; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.